135 related articles for article (PubMed ID: 214796)
1. Isolation of host-range variants of mouse mammary tumor viruses that efficiently infect cells in vitro.
Howard DK; Schlom J
Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5718-22. PubMed ID: 214796
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a series of novel variants of murine mammary tumor viruses with broadened host ranges.
Howard DK; Schlom J
Int J Cancer; 1980 May; 25(5):647-54. PubMed ID: 6246012
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a C3Hf mammary tumor cell line expressing endogenous mouse mammary tumor virus: antigenic and genetic relationships of this virus with highly oncogenic mouse mammary tumor viruses.
Arthur LO; Lovinger GG; Schochetman G
J Virol; 1979 Dec; 32(3):852-9. PubMed ID: 92576
[TBL] [Abstract][Full Text] [Related]
4. Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.
Schochetman G; Arthur LO; Long CW; Massey RJ
J Virol; 1979 Oct; 32(1):131-9. PubMed ID: 94356
[TBL] [Abstract][Full Text] [Related]
5. Type-specific antigenic determinants on the major external glycoprotein of high- and low-oncogenic murine mammary tumor viruses.
Teramoto YA; Kufe D; Schlom J
J Virol; 1977 Nov; 24(2):525-33. PubMed ID: 72161
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
Ritzi EM; Smith BA; Stolfi RL; Martin DS
Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
[TBL] [Abstract][Full Text] [Related]
7. Strain-specific markers for the major structural proteins of highly oncogenic murine mammary tumor viruses by tryptic peptide analyses.
Gautsch JW; Lerner R; Howard D; Teramoto YA; Schlom J
J Virol; 1978 Sep; 27(3):688-99. PubMed ID: 212589
[TBL] [Abstract][Full Text] [Related]
8. Immunological characterization of mouse mammary tumor virus p10 and its presence in mammary tumors and sera of tumor-bearing mice.
Arthur LO; Fine DL
J Virol; 1979 Apr; 30(1):148-56. PubMed ID: 90156
[TBL] [Abstract][Full Text] [Related]
9. Multiple antigenic determinants on the major surface glycoprotein of murine mammary tumor viruses.
Teramoto YA; Kufe D; Schlom J
Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3564-8. PubMed ID: 71733
[TBL] [Abstract][Full Text] [Related]
10. Mouse mammary tumor virus (MMTV) infection in SWISS and RIII mice. Correlation between resistance to exogenous infection and anti-MMTV serum response.
Hainaut P; Vaira D; Francois C; Calberg-Bacq CM
Arch Virol; 1990; 113(1-2):35-52. PubMed ID: 2167058
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mouse mammary tumor viruses propagated in heterologous cells.
Howard DK; Colcher D; Teramoto YA; Young JM; Schlom J
Cancer Res; 1977 Aug; 37(8 Pt 1):2696-704. PubMed ID: 68813
[TBL] [Abstract][Full Text] [Related]
12. C3H strain of mouse mammary tumour virus, like GR strain, infects human mammary epithelial cells, albeit less efficiently than murine mammary epithelial cells.
Konstantoulas CJ; Indik S
J Gen Virol; 2015 Mar; 96(Pt 3):650-662. PubMed ID: 25491421
[TBL] [Abstract][Full Text] [Related]
13. Long-term primary culture of mouse mammary tumor cells: production of virus.
Young LJ; Cardiff RD; Ashley RL
J Natl Cancer Inst; 1975 May; 54(5):1215-21. PubMed ID: 165313
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids stimulate the release of a viral tumor marker (MMTV gp52) while inhibiting tumor cell growth.
Ritzi EM; Walthall EB
J Steroid Biochem; 1989 Apr; 32(4):499-505. PubMed ID: 2542692
[TBL] [Abstract][Full Text] [Related]
15. Mouse mammary tumor virus genome expression in chemical carcinogen-induced mammary tumors in low- and high-tumor-incidence mouse strains.
Dusing-Swartz S; Medina D; Butel JS; Socher SH
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5360-4. PubMed ID: 228289
[TBL] [Abstract][Full Text] [Related]
16. Single amino acid substitution (G42E) in the receptor binding domain of mouse mammary tumour virus envelope protein facilitates infection of non-murine cells in a transferrin receptor 1-independent manner.
Konstantoulas CJ; Lamp B; Rumenapf TH; Indik S
Retrovirology; 2015 May; 12():43. PubMed ID: 25980759
[TBL] [Abstract][Full Text] [Related]
17. Estimation of mouse mammary tumor virus gp52 abundance by protein A assay: a comparison of viral antigen expression on C3H and GR mammary tumor cells.
Callis AH; Ritzi EM
Intervirology; 1981; 15(2):111-20. PubMed ID: 6271704
[TBL] [Abstract][Full Text] [Related]
18. Differential host ranges for in vitro infectivity of mouse mammary tumour viruses.
Howard DK; Schlom J
J Gen Virol; 1980 Apr; 47(2):439-48. PubMed ID: 6245180
[TBL] [Abstract][Full Text] [Related]
19. C3H/HeN mammary tumor-bearing mice develop type-specific neutralizing antibodies and group-specific precipitating antibodies for the mouse mammary tumor virus.
Massey R; Arthur LO; Long CW; Schochetman G
J Virol; 1980 Jan; 33(1):123-8. PubMed ID: 6154146
[TBL] [Abstract][Full Text] [Related]
20. Shedding of virus-free MMTV gp52 by nonproducer mammary tumor cells: a source of tumor marker in the presence and absence of dexamethasone.
Ritzi EM; Walthall EB
Intervirology; 1989; 30(2):102-10. PubMed ID: 2542180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
